New sensitive method for the measurement of lysozyme and lactoferrin for the assessment of innate mucosal immunity. Part I: Time-resolved immunofluorometric assay in serum and mucosal secretions

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 2, 2003, Pages 127-133

  Bard, Emmanuel ^a   Laibe, Sophy ^a   Bettinger, Dominique ^a   Riethmuller, Didier ^a,b   Biichlé, Sabeha ^a   Seilles, Estelle ^a   Meillet, Dominique ^a,c  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c Laboratoire de Biologie   (France)

Author keywords

Innate immunity; Lactoferrin; Lysozyme; Time resolved immunofluorometric assay

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; LACTOFERRIN; LYSOZYME;

ADULT; BLOOD ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ASSAY; EXCRETION; FECES ANALYSIS; FEMALE; FLUOROMETRY; HUMAN; IMMUNOASSAY; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; MUCOSAL IMMUNITY; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; QUANTITATIVE ASSAY; REVIEW; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; VAGINA SECRETION; VALIDATION PROCESS;

ADOLESCENT; ADULT; ALBUMINS; ALPHA 1-ANTITRYPSIN; BODILY SECRETIONS; FECES; FEMALE; FLUOROIMMUNOASSAY; HUMANS; LACTOFERRIN; MALE; MIDDLE AGED; MUCOUS MEMBRANE; MURAMIDASE; REPRODUCIBILITY OF RESULTS; SALIVA; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0037225020     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.021     Document Type: Review

References (46)

1. Medzhitov R, Janeway C. Innate immunity. N Engl J Med 2000; 343:338-44.
2. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999; 284:1313-8.
3. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394-7.
4. Pruitt KM, Rahemtulla B, Rahemtulla F, Russell MW: Innate humoral factors. In: Ogra PL, Mestecky J, Lamm ME, et al., editors. Handbook of mucosal immunology, vol 1. London: Academic Press, 1999; 65-88.
5. Yeh CK, Dodds MW, Zuo P, Johnson DA. A population-based study of salivary lysozyme concentrations and candida counts. Arch Oral Biol 1997; 42:25-31.
6. Wu T, Samaranayake LP, Leung WK, Sullivan PA. Inhibition of growth and secreted aspartyl proteinase production in Candida albicans by lysozyme. J Med Microbiol 1999; 48:721-30.
7. Mandel ID, Barr CE, Turgeon L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 1992; 21:209-13.
8. Marquis G, Montplaisir S, Garzon S, Strykowski H, Auger P. Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans. Lab Invest 1982; 46:627-36.
9. Samaranayake YH, MacFarlane TW, Aitchison TC, Samaranayake LP. The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media. Oral Microbiol Immunol 1993; 8:177-81.
10. Baynes RD, Bezwoda WR. Lactoferrin and the inflammatory response. Adv Exp Med Biol 1994; 357:133-41.
11. van der Strate BW, Harmsen MC, The TH, Sprenger HG, de Vries H, Eikelboom MC, et al. Plasma lactoferrin levels are decreased in end-stage AIDS patients. Viral Immunol 1999; 12:197-203.
12. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995; 80:252-67.
13. Kanyshkova TG, Buneva VN, Nevinsky GA. Lactoferrin and its biological functions. Biochemistry (Mosc) 2001; 66:1-7.
14. Harmsen MC, Swart PJ, de Bethune MP, Pauwels R, de Clercq E, The TH, et al. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infect Dis 1995; 172: 380-8.
15. Marchetti M, Longhi C, Conte MP, Pisani S, Valenti P, Seganti L. Lactoferrin inhibits Herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res 1996; 29: 221-31.
16. Swart PJ, Kuipers ME, Smit C, Pauwels R, deBethune MP, de Clercq E, et al. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res Hum Retroviruses 1996; 12:769-75.
17. Muller F, Holberg-Petersen M, Rollag H, Degre M, Brandtzaeg P, Froland SS. Non specific oral immunity in individuals with HIV infection. J Acquir Immune Defic Syndr 1992; 5:46-51.
18. Moriuchi M, Moriuchi H. A milk protein lactoferrin enhances human T cell leukemia virus type I and suppresses HIV-1 infection. J Immunol 2001; 166:4231-6.
19. Ekstrand B, Bjorck L. Fast protein liquid chromatography of antibacterial components in milk. Lactoperoxidase, lactoferrin and lysozyme. J Chromatogr 1986; 358:429-33.
20. Sanchez-Pozo A, Lopez J, Pita ML, Izquierdo A, Guerrero E, Sanchez-Medina F, et al. Changes in the protein fractions of human milk during lactation. Ann Nutr Metab 1986; 30:15-20.
21. Goldman AS, Garza C, Nichols BL, Goldblum RM. Immunologic factors in human milk during the first year of lactation. J Pediatr 1982; 100:563-7.
22. Hennart PF, Brasseur DJ, Delogne-Desnoeck JB, Dramaix MM, Robyn CE. Lysozyme, lactoferrin, and secretory immunoglobulin A content in breast milk: influence of duration of lactation, nutrition status, prolactin status, and parity of mother. Am J Clin Nutr 1991; 53:32-9.
23. Hirai Y, Kawakata N, Satoh K, Ikeda Y, Hisayasu S, Orimo H, et al. Concentrations of lactoferrin and iron in human milk at different stages of lactation. J Nutr Sci Vitaminol (Tokyo) 1990; 36:531-44.
24. Meillet D, Raichvarg D, Tallet F, Savel J, Yonger J, Gobert JG. Measurement of total, monomeric and polymeric IgA in human faeces by electroimmunodiffusion. Clin Exp Immunol 1987; 69:142-7.
25. Abrink M, Larsson E, Gobl A, Hellman L. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int 2000; 57:2004-10.
26. Bard E, Riethmuller D, Biichle S, Meillet D, Pretet JL, Mougin C, et al. Validation of high sensitive immuno-enzymatic assay to establish the origin of immunoglobulins in female genital secretions. J Immunoassay 2002; 23:145-162.
27. Hemmila I. Lanthanides as probes for time-resolved fluorometric immunoassays. Scand J Clin Lab Invest 1988; 48:389-99.
28. Dickson EF, Pollak A, Diamandis EP. Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol Ther 1995; 66:207-35.
29. Benhamou Y, Kapel N, Hoang C, Matta H, Meillet D, Magne D, et al. Inefficacy of intestinal secretory immune response to Cryptosporidium in acquired immunodeficiency syndrome. Gastroenterology 1995; 108:627-35.
30. Belec L, Dupre T, Prazuck T, Tevi-Benissan C, Kanga JM, Pathey O, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995; 172:691-7.
31. Belec L, Meillet D, Levy M, Georges A, Tevi-Benissan C, Pillot J. Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin Diagn Lab Immunol 1995; 2:57-61.
32. Vassault A, Azzedine MC, Bailly M, Cam G, Dumont G, Ekindjian OG, et al. French Society of Clinical Biology. Commission for Validation of Methods. Ann Biol Clin (Paris) 1986; 44:679-755.
33. Kapel N, Meillet D, Favennec L, Magne D, Raichvarg D, Gobert JG. Evaluation of intestinal clearance and faecal excretion of alpha 1-antiproteinase and immunoglobulins during Crohn's disease and ulcerative colitis. Eur J Clin Chem Clin Biochem 1992; 30:197-202.
34. Delacroix DL. The human immunoglobulin: a system, its vascular compartment. Medicine thesis. Catholic University, 1985.
35. Jonard PP, Rambaud JC, Dive C, Vaerman JP, Galian A, Delacroix DL. Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest 1984; 74:525-35.
36. Cuilliere ML, Montagne P, Mole C, Bene MC, Faure G. Microparticle-enhanced nephelometric immunoassay of lactoferrin in human milk. J Clin Lab Anal 1997; 11:239-43.
37. Kapel N, Meillet D, Raichvarg D, Gobert JG. Serum and faecal proteins during Crohn's disease. Protides of the biological fluids, London: Pergamon Press, 1989.
38. Montagne P, Cuilliere ML, Mole C, Bene MC, Faure G. Microparticle-enhanced nephelometric immunoassay of lysozyme in milk and other human body fluids. Clin Chem 1998; 44:1610-5.
39. Belec L, Meillet D, Hernvann A, Gresenguet G, Gherardi R. Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states. Clin Diagn Lab Immunol 1994; 1:117-20.
40. Coutlee F, Hankins C, Lapointe N. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction. J Med Virol 1997; 51:42-7.
41. Morrison EA, Goldberg GL, Hagan RJ, Kadish AS, Burk RD. Self-administered home cervicovaginal lavage: a novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections. Am J Obstet Gynecol 1992; 167:104-7.
42. Meillet D, Kapel N, Favennec L, Raichvarg D, Savel J, Gobert JG. Intestinal humoral immunity and digestive opportunistic infections associated with AIDS. C R Seances Soc Biol Clin 1991; 185:63-8.
43. Walmer DK, Wrona MA, Hughes CL, Nelson KG. Lactoferrin expression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology 1992; 131:1458-66.
44. Tenovuo J, Lumikari M, Soukka T. Salivary lysozyme, lactoferrin and peroxidases: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. Proc Finn Dent Soc 1991; 87:197-208.
45. Xu YY, Samaranayake YH, Samaranayake LP, Nikawa H. In vitro susceptibility of Candida species to lactoferrin. Med Mycol 1999; 37:35-41.
46. Laibe S, Bard E, Biichlé S, Vieille S, Millon L, Drobacheff C, et al. A new sensitive method for the measurement of lysozyme and lactoferrin to explore mucosal innate immunity. Part II: Time resolved-immunofluorometric assay used in HIV patients with oral candidiasis. Clin Chem Lab Med 2002; Submitted).